✦ LIBER ✦

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

✍ Scribed by Pernot, Simon; Mitry, Emmanuel; Samalin, Emmanuelle; Dahan, Laetitia; Dalban, CÃ©cile; Ychou, Marc; Seitz, Jean-FranÃ§ois; Turki, Hajer; Mazard, Thibault; Zaanan, Aziz; LepÃ¨re, CÃ©line; Vaillant, Jean-Nicolas; Landi, Bruno; Rougier, Philippe; Taieb, Julien

Book ID: 121372613
Publisher: Springer
Year: 2013
Tongue: English
Weight: 216 KB
Volume: 17
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-013-0266-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety and efficacy of fluorouracil,

The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial

✍ Abeer Hussien Anter, Rasha Mohamed Abdel-Latif 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 246 KB

Combination of cisplatin/S-1 in the trea

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

✍ Ajani, J.A.; Buyse, M.; Lichinitser, M.; Gorbunova, V.; Bodoky, G.; Douillard, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 502 KB